This agrees with the previous findings from a genetically engineered mouse model with RB1/TP53/Myc mutations, that depletion of the neuroendocrine lineage driver Ascl1 led to the emergence of osteosarcoma and chondroid tumors [29]. This evidence concerns the gene TP53 and osteosarcoma.